Sayaka Tsukioka

Thymidylate synthase as a determinant of pemetrexed sensitivity in non-small cell lung cancer

Ken Takezawa, Isamu Okamoto, Wataru Okamoto et al. · British Journal of Cancer · 2011 · 169 citations · Full text

Medicine, Oncology, Pharmacology +13

Synergistic antitumor effect of S-1 and the epidermal growth factor receptor inhibitor gefitinib in non-small cell lung cancer cell lines: role of gefitinib-induced down-regulation of thymidylate synthase

Takafumi Okabe, Isamu Okamoto, Sayaka Tsukioka et al. · Molecular Cancer Therapeutics · 2008 · 78 citations

Medicine, Oncology, Pharmacology +15

Different histological types of non‐small cell lung cancer have distinct folate and DNA methylation levels

MingJi Jin, Kazuyuki Kawakami, Yousuke Fukui et al. · Cancer Science · 2009 · 50 citations · Full text

Medicine, Molecular Biology, Oncology +14

Addition of S-1 to the Epidermal Growth Factor Receptor Inhibitor Gefitinib Overcomes Gefitinib Resistance in Non–small cell Lung Cancer Cell Lines with<i>MET</i>Amplification

Takafumi Okabe, Isamu Okamoto, Sayaka Tsukioka et al. · Clinical Cancer Research · 2009 · 47 citations · Full text

Medicine, Oncology, Pharmacology +14

dUTPase inhibition confers susceptibility to a thymidylate synthase inhibitor in DNA‐repair‐defective human cancer cells

Tatsushi Yokogawa, Wakako Yano, Sayaka Tsukioka et al. · Cancer Science · 2020 · 41 citations · Full text

Life Sciences, Molecular Biology, Oncology +17